First Serial Assessment at 6 Months and 2 Years of the Second Generation of Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold-Reference-Cited by-同舟云学术

First Serial Assessment at 6 Months and 2 Years of the Second Generation of Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold

Published:2012-10 Issue:5 Volume:5 Page:620-632
ISSN:1941-7640
Container-title:Circulation: Cardiovascular Interventions
language:en
Short-container-title:Circ Cardiovasc Interv

Author:

Ormiston John A.¹,Serruys Patrick W.¹,Onuma Yoshinobu¹,van Geuns Robert-Jan¹,de Bruyne Bernard¹,Dudek Dariusz¹,Thuesen Leif¹,Smits Pieter C.¹,Chevalier Bernard¹,McClean Dougal¹,Koolen Jacques¹,Windecker Stephan¹,Whitbourn Robert¹,Meredith Ian¹,Dorange Cecile¹,Veldhof Susan¹,Hebert Karine Miquel¹,Rapoza Richard¹,Garcia-Garcia Hector M.¹

Affiliation:

1. From the Auckland City Hospital, Auckland, New Zealand (J.A.O.); ThoraxCenter, Erasmus Medical Center, Rotterdam, the Netherlands (P.W.S., Y.O., R.-J.v.G.); Cardiovascular Center, Aalst, Belgium (B.d.B.); Jagiellonian University, Krakow, Poland (D.D.); Skejby Sygehus University Hospital, Aarhus, Denmark (L.T.); Maasstad Hospital, Rotterdam, the Netherlands (P.C.S.); Institut Jacques Cartier, Massy, France (B.C.); Christchurch Hospital, Christchurch, New Zealand (D.M.C.); Catharina Hospital,...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference45 articles.

1. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial

2. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods

3. Biodegradable drug eluting stents: invasive and non-invasive imaging.;Kukreja N;EuroIntervention,2006

4. First-in-human implantation of a fully bioabsorbable drug-eluting stent: The BVS poly-L-lactic acid everolimus-eluting coronary stent

5. Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery Stenosis

Cited by 187 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The unpredictable resorption of bioresorbable scaffolds—A tale of two ABSORBs;Clinical Case Reports;2024-05-31

2. Revolutionizing Cardiovascular Frontiers: A Dive Into Cutting-Edge Innovations in Coronary Stent Technology;Cardiology in Review;2024-05-06

3. Long-term intracoronary imaging and physiological measurements of bioresorbable scaffolds and untreated atherosclerotic plaques;International Journal of Cardiology;2024-01

4. First-in-human evaluation of a novel ultrathin sirolimus- eluting iron bioresorbable scaffold: 3-year outcomes of the IBS-FIM trial;EUROINTERVENTION;2023

5. Challenges of the newer generation of resorbable magnesium scaffolds: Lessons from failure mechanisms of the past generation;Journal of Cardiology;2023-02